Supersulphides provide airway protection in viral and chronic lung diseases

被引:0
|
作者
Tetsuro Matsunaga
Hirohito Sano
Katsuya Takita
Masanobu Morita
Shun Yamanaka
Tomohiro Ichikawa
Tadahisa Numakura
Tomoaki Ida
Minkyung Jung
Seiryo Ogata
Sunghyeon Yoon
Naoya Fujino
Yorihiko Kyogoku
Yusaku Sasaki
Akira Koarai
Tsutomu Tamada
Atsuhiko Toyama
Takakazu Nakabayashi
Lisa Kageyama
Shigeru Kyuwa
Kenji Inaba
Satoshi Watanabe
Péter Nagy
Tomohiro Sawa
Hiroyuki Oshiumi
Masakazu Ichinose
Mitsuhiro Yamada
Hisatoshi Sugiura
Fan-Yan Wei
Hozumi Motohashi
Takaaki Akaike
机构
[1] Tohoku University Graduate School of Medicine,Department of Environmental Medicine and Molecular Toxicology
[2] Tohoku University Graduate School of Medicine,Department of Respiratory Medicine
[3] Shimadzu Corporation,Analytical and Measuring Instruments Division
[4] Tohoku University,Bio
[5] The University of Tokyo,Structural Chemistry, Graduate School of Pharmaceutical Sciences
[6] Tohoku University,Laboratory of Biomedical Science, Department of Veterinary Medical Science, Graduate School of Agricultural and Life Sciences
[7] National Institute of Oncology,Institute of Multidisciplinary Research for Advanced Materials
[8] Kumamoto University,Department of Molecular Immunology and Toxicology
[9] Kumamoto University,Department of Microbiology, Graduate School of Medical Sciences
[10] Tohoku University,Department of Immunology, Graduate School of Medical Sciences
[11] Tohoku University,Department of Modomics Biology and Medicine, Institute of Development, Aging and Cancer
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Supersulphides are inorganic and organic sulphides with sulphur catenation with diverse physiological functions. Their synthesis is mainly mediated by mitochondrial cysteinyl-tRNA synthetase (CARS2) that functions as a principal cysteine persulphide synthase (CPERS). Here, we identify protective functions of supersulphides in viral airway infections (influenza and COVID-19), in aged lungs and in chronic lung diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF). We develop a method for breath supersulphur-omics and demonstrate that levels of exhaled supersulphides increase in people with COVID-19 infection and in a hamster model of SARS-CoV-2 infection. Lung damage and subsequent lethality that result from oxidative stress and inflammation in mouse models of COPD, IPF, and ageing were mitigated by endogenous supersulphides production by CARS2/CPERS or exogenous administration of the supersulphide donor glutathione trisulphide. We revealed a protective role of supersulphides in airways with various viral or chronic insults and demonstrated the potential of targeting supersulphides in lung disease.
引用
收藏
相关论文
共 50 条
  • [1] Supersulphides provide airway protection in viral and chronic lung diseases
    Matsunaga, Tetsuro
    Sano, Hirohito
    Takita, Katsuya
    Morita, Masanobu
    Yamanaka, Shun
    Ichikawa, Tomohiro
    Numakura, Tadahisa
    Ida, Tomoaki
    Jung, Minkyung
    Ogata, Seiryo
    Yoon, Sunghyeon
    Fujino, Naoya
    Kyogoku, Yorihiko
    Sasaki, Yusaku
    Koarai, Akira
    Tamada, Tsutomu
    Toyama, Atsuhiko
    Nakabayashi, Takakazu
    Kageyama, Lisa
    Kyuwa, Shigeru
    Inaba, Kenji
    Watanabe, Satoshi
    Nagy, Peter
    Sawa, Tomohiro
    Oshiumi, Hiroyuki
    Ichinose, Masakazu
    Yamada, Mitsuhiro
    Sugiura, Hisatoshi
    Wei, Fan-Yan
    Motohashi, Hozumi
    Akaike, Takaaki
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Respiratory Viral Infections in Chronic Lung Diseases
    Britto, Clemente J.
    Brady, Virginia
    Lee, Seiwon
    Dela Cruz, Charles S.
    CLINICS IN CHEST MEDICINE, 2017, 38 (01) : 87 - +
  • [3] Editorial: Chronic airway diseases, lung cancer, and their interaction
    Liu, Yi
    Zhang, Youming
    FRONTIERS IN MEDICINE, 2023, 10
  • [4] Protection from acute and chronic lung diseases by curcumin
    Venkatesan, Narayanan
    Punithavathi, Durairaj
    Babu, Mary
    MOLECULAR TARGETS AND THERAPEUTIC USES OF CURCUMIN IN HEALTH AND DISEASE, 2007, 595 : 379 - 405
  • [5] Pneumococcal infections and protection with vaccination in adult chronic lung diseases
    Karadeniz, Gulistan
    Kilinc, Oguz
    Olmez, Ayse
    Ozhan, Mustafa Hikmet
    Ozlu, Tevfik
    Ozyurek, Berna Akinci
    Pullukcu, Husnu
    Saltoglu, Nese
    Sayiner, Abdullah
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2020, 68 (03): : 305 - 320
  • [6] CHRONIC VIRAL DISEASES
    BERRIS, B
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1986, 135 (11) : 1260 - 1268
  • [7] Viral infections in obstructive airway diseases
    Seemungal, TAR
    Wedzicha, JA
    CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (02) : 111 - 116
  • [8] CHRONIC VIRAL DISEASES
    SHEAR, NH
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1987, 136 (04) : 326 - 326
  • [9] Personalising airway clearance in chronic suppurative lung diseases: a scoping review
    Schofield, Lynne M.
    Singh, Sally J.
    Yousaf, Zarah
    Wild, Jim M.
    Hind, Daniel
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [10] Modifying Macrophage Phenotypes to Dampen Airway Inflammation in Chronic Lung Diseases
    Hisert, K. B.
    Ochoa, A.
    Skinner, K.
    Long, M.
    Schoenfelt, K.
    Janssen, W. J.
    Becker, L.
    Manicone, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205